2019 Canadian Cardiovascular Society Position Statement for Transcatheter Aortic Valve Implantation

Publication date: November 2019Source: Canadian Journal of Cardiology, Volume 35, Issue 11Author(s): Anita W. Asgar, Maral Ouzounian, Corey Adams, Jonathan Afilalo, Stephen Fremes, Sandra Lauck, Jonathan Leipsic, Nico Piazza, Josep Rodes-Cabau, Robert Welsh, Harindra C. Wijeysundera, John G. WebbAbstractTranscatheter aortic valve implantation (TAVI) or replacement has rapidly changed the treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care for patients believed to be inoperable or at high surgical risk, and a reasonable alternative to surgical aortic valve replacement for those at intermediate surgical risk. Recent clinical trial data have shown the benefits of this technology in patients at low surgical risk as well. This update of the 2012 Canadian Cardiovascular Society TAVI position statement incorporates clinical evidence to provide a practical framework for patient selection that does not rely on surgical risk scores but rather on individual patient evaluation of risk and benefit from either TAVI or surgical aortic valve replacement. In addition, this statement features new wait time categories and treatment time goals for patients accepted for TAVI. Institutional requirements and recommendations for operator training and maintenance of competency have also been revised to reflect current standards. Procedural considerations such as decision-making for concomitant coronary intervention, antiplatelet therapy after intervention, an...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research